Haemonetics (HAE) Assets Average (2010 - 2026)

Haemonetics' Assets Average history runs 17 years deep, the most recent figure standing at $2.4 billion for Q1 2026.

• In Q1 2026, Assets Average fell 1.91% year-over-year to $2.4 billion; the TTM figure through Mar 2026 stood at $2.4 billion (down 1.91% YoY), while the FY2026 annual figure was $2.4 billion, up 4.31% from the prior year.
• Assets Average was $2.4 billion for Q1 2026 at Haemonetics, down from $2.5 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.5 billion in Q3 2024 to a low of $1.8 billion in Q1 2022.
• Historically, Assets Average has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2023.
• The sharpest annual moves came in 2022 and 2025: Assets Average soared 32.77% in 2022, then dropped 3.2% in 2025.
• A 5-year view of Assets Average shows it stood at $1.9 billion in 2022, then gained by 12.52% to $2.1 billion in 2023, then increased by 20.06% to $2.5 billion in 2024, then declined by 2.44% to $2.5 billion in 2025, then decreased by 0.94% to $2.4 billion in 2026.
• The last three Assets Average figures came in at $2.4 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.